csirt@kutim:~/threat-intel/cve/CVE-2021-37687

Katalog CVE

CVSS 5.5 · Medium EPSS 0,19%

Kerentanan Out-of-bounds Read pada google tensorflow. Skor CVSS 3.1 5.5 (Medium) menurut NVD.

Deskripsi (NVD)

TensorFlow is an end-to-end open source platform for machine learning. In affected versions TFLite's [`GatherNd` implementation](https://github.com/tensorflow/tensorflow/blob/149562d49faa709ea80df1d99fc41d005b81082a/tensorflow/lite/kernels/gather_nd.cc#L124) does not support negative indices but there are no checks for this situation. Hence, an attacker can read arbitrary data from the heap by carefully crafting a model with negative values in `indices`. Similar issue exists in [`Gather` implementation](https://github.com/tensorflow/tensorflow/blob/149562d49faa709ea80df1d99fc41d005b81082a/tensorflow/lite/kernels/gather.cc). We have patched the issue in GitHub commits bb6a0383ed553c286f87ca88c207f6774d5c4a8f and eb921122119a6b6e470ee98b89e65d721663179d. The fix will be included in TensorFlow 2.6.0. We will also cherrypick this commit on TensorFlow 2.5.1, TensorFlow 2.4.3, and TensorFlow 2.3.4, as these are also affected and still in supported range.

Rincian

Terbit di NVD
12 Agustus 2021
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
5.5 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-125: Out-of-bounds Read
EPSS (30 hari)
0,19% peluang dieksploitasi; lebih tinggi dari 8,0% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
google tensorflow Versi 2.3.0 hingga sebelum 2.3.4
google tensorflow Versi 2.4.0 hingga sebelum 2.4.3
google tensorflow Versi 2.5.0
google tensorflow Versi 2.6.0 rc0
google tensorflow Versi 2.6.0 rc1
google tensorflow Versi 2.6.0 rc2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.